Cargando…

Using donor funding to catalyse investment in malaria prevention in Ghana: an analysis of the potential impact on public and private sector expenditure

BACKGROUND: An estimated 1.5 billion malaria cases and 7.6 million malaria deaths have been averted globally since 2000; long-lasting insecticidal nets (LLINs) have contributed an estimated 68% of this reduction. Insufficient funding at the international and domestic levels poses a significant threa...

Descripción completa

Detalles Bibliográficos
Autores principales: Paintain, Lucy, Kpabitey, Richard, Nyanor-Fosu, Felix, Piccinini Black, Danielle, Bertram, Kathryn, Webster, Jayne, Goodman, Catherine, Lynch, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235193/
https://www.ncbi.nlm.nih.gov/pubmed/35761255
http://dx.doi.org/10.1186/s12936-022-04218-2
_version_ 1784736259418095616
author Paintain, Lucy
Kpabitey, Richard
Nyanor-Fosu, Felix
Piccinini Black, Danielle
Bertram, Kathryn
Webster, Jayne
Goodman, Catherine
Lynch, Matt
author_facet Paintain, Lucy
Kpabitey, Richard
Nyanor-Fosu, Felix
Piccinini Black, Danielle
Bertram, Kathryn
Webster, Jayne
Goodman, Catherine
Lynch, Matt
author_sort Paintain, Lucy
collection PubMed
description BACKGROUND: An estimated 1.5 billion malaria cases and 7.6 million malaria deaths have been averted globally since 2000; long-lasting insecticidal nets (LLINs) have contributed an estimated 68% of this reduction. Insufficient funding at the international and domestic levels poses a significant threat to future progress and there is growing emphasis on the need for enhanced domestic resource mobilization. The Private Sector Malaria Prevention (PSMP) project was a 3-year intervention to catalyse private sector investment in malaria prevention in Ghana. METHODS: To assess value for money of the intervention, non-donor expenditure in the 5 years post-project catalysed by the initial donor investment was predicted. Non-donor expenditure catalysed by this investment included: workplace partner costs of malaria prevention activities; household costs in purchasing LLINs from retail outlets; domestic resource mobilization (public sector financing and private investors). Annual ratios of projected non-donor expenditure to annualized donor costs were calculated for the 5 years post-project. Alternative scenarios were constructed to explore uncertainty around future consequences of the intervention. RESULTS: The total donor financial cost of the 3-year PSMP project was USD 4,418,996. The average annual economic donor cost per LLIN distributed through retail sector and workplace partners was USD 21.17 and USD 7.55, respectively. Taking a 5-year post-project time horizon, the annualized donor investment costs were USD 735,805. In the best-case scenario, each USD of annualized donor investment led to USD 4.82 in annual projected non-donor expenditure by the fifth-year post-project. With increasingly conservative assumptions around the project consequences, this ratio decreased to 3.58, 2.16, 1.07 and 0.93 in the “very good”, “good”, “poor” and “worst” case scenarios, respectively. This suggests that in all but the worst-case scenario, donor investment would be exceeded by the non-donor expenditure it catalysed. CONCLUSIONS: The unit cost per net delivered was high, reflecting considerable initial investment costs and relatively low volumes of LLINs sold during the short duration of the project. However, taking a longer time horizon and broader perspective on the consequences of this complex catalytic intervention suggests that considerable domestic resources for malaria control could be mobilized, exceeding the value of the initial donor investment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-022-04218-2.
format Online
Article
Text
id pubmed-9235193
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92351932022-06-28 Using donor funding to catalyse investment in malaria prevention in Ghana: an analysis of the potential impact on public and private sector expenditure Paintain, Lucy Kpabitey, Richard Nyanor-Fosu, Felix Piccinini Black, Danielle Bertram, Kathryn Webster, Jayne Goodman, Catherine Lynch, Matt Malar J Research BACKGROUND: An estimated 1.5 billion malaria cases and 7.6 million malaria deaths have been averted globally since 2000; long-lasting insecticidal nets (LLINs) have contributed an estimated 68% of this reduction. Insufficient funding at the international and domestic levels poses a significant threat to future progress and there is growing emphasis on the need for enhanced domestic resource mobilization. The Private Sector Malaria Prevention (PSMP) project was a 3-year intervention to catalyse private sector investment in malaria prevention in Ghana. METHODS: To assess value for money of the intervention, non-donor expenditure in the 5 years post-project catalysed by the initial donor investment was predicted. Non-donor expenditure catalysed by this investment included: workplace partner costs of malaria prevention activities; household costs in purchasing LLINs from retail outlets; domestic resource mobilization (public sector financing and private investors). Annual ratios of projected non-donor expenditure to annualized donor costs were calculated for the 5 years post-project. Alternative scenarios were constructed to explore uncertainty around future consequences of the intervention. RESULTS: The total donor financial cost of the 3-year PSMP project was USD 4,418,996. The average annual economic donor cost per LLIN distributed through retail sector and workplace partners was USD 21.17 and USD 7.55, respectively. Taking a 5-year post-project time horizon, the annualized donor investment costs were USD 735,805. In the best-case scenario, each USD of annualized donor investment led to USD 4.82 in annual projected non-donor expenditure by the fifth-year post-project. With increasingly conservative assumptions around the project consequences, this ratio decreased to 3.58, 2.16, 1.07 and 0.93 in the “very good”, “good”, “poor” and “worst” case scenarios, respectively. This suggests that in all but the worst-case scenario, donor investment would be exceeded by the non-donor expenditure it catalysed. CONCLUSIONS: The unit cost per net delivered was high, reflecting considerable initial investment costs and relatively low volumes of LLINs sold during the short duration of the project. However, taking a longer time horizon and broader perspective on the consequences of this complex catalytic intervention suggests that considerable domestic resources for malaria control could be mobilized, exceeding the value of the initial donor investment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12936-022-04218-2. BioMed Central 2022-06-27 /pmc/articles/PMC9235193/ /pubmed/35761255 http://dx.doi.org/10.1186/s12936-022-04218-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Paintain, Lucy
Kpabitey, Richard
Nyanor-Fosu, Felix
Piccinini Black, Danielle
Bertram, Kathryn
Webster, Jayne
Goodman, Catherine
Lynch, Matt
Using donor funding to catalyse investment in malaria prevention in Ghana: an analysis of the potential impact on public and private sector expenditure
title Using donor funding to catalyse investment in malaria prevention in Ghana: an analysis of the potential impact on public and private sector expenditure
title_full Using donor funding to catalyse investment in malaria prevention in Ghana: an analysis of the potential impact on public and private sector expenditure
title_fullStr Using donor funding to catalyse investment in malaria prevention in Ghana: an analysis of the potential impact on public and private sector expenditure
title_full_unstemmed Using donor funding to catalyse investment in malaria prevention in Ghana: an analysis of the potential impact on public and private sector expenditure
title_short Using donor funding to catalyse investment in malaria prevention in Ghana: an analysis of the potential impact on public and private sector expenditure
title_sort using donor funding to catalyse investment in malaria prevention in ghana: an analysis of the potential impact on public and private sector expenditure
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235193/
https://www.ncbi.nlm.nih.gov/pubmed/35761255
http://dx.doi.org/10.1186/s12936-022-04218-2
work_keys_str_mv AT paintainlucy usingdonorfundingtocatalyseinvestmentinmalariapreventioninghanaananalysisofthepotentialimpactonpublicandprivatesectorexpenditure
AT kpabiteyrichard usingdonorfundingtocatalyseinvestmentinmalariapreventioninghanaananalysisofthepotentialimpactonpublicandprivatesectorexpenditure
AT nyanorfosufelix usingdonorfundingtocatalyseinvestmentinmalariapreventioninghanaananalysisofthepotentialimpactonpublicandprivatesectorexpenditure
AT piccininiblackdanielle usingdonorfundingtocatalyseinvestmentinmalariapreventioninghanaananalysisofthepotentialimpactonpublicandprivatesectorexpenditure
AT bertramkathryn usingdonorfundingtocatalyseinvestmentinmalariapreventioninghanaananalysisofthepotentialimpactonpublicandprivatesectorexpenditure
AT websterjayne usingdonorfundingtocatalyseinvestmentinmalariapreventioninghanaananalysisofthepotentialimpactonpublicandprivatesectorexpenditure
AT goodmancatherine usingdonorfundingtocatalyseinvestmentinmalariapreventioninghanaananalysisofthepotentialimpactonpublicandprivatesectorexpenditure
AT lynchmatt usingdonorfundingtocatalyseinvestmentinmalariapreventioninghanaananalysisofthepotentialimpactonpublicandprivatesectorexpenditure